Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Cycling Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Patients With Hypertension
1 other identifier
interventional
45
1 country
1
Brief Summary
Hypertension or high blood pressure is defined as when the pressure in the blood vessels is too high. According to Joint National Committee 8 (JNC 8) Guidelines, hypertension is defined as systolic blood pressure level of more than ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg. This study aims to study the combined effects of Pilates breathing, Diaphragmatic breathing and Moderate Intensity Continuous Cycling Training on blood pressure, chest expansion, pulmonary function and quality of life. Aerobic physical activity moderate intensity continuous training: (55%- 70% of maximal heart rate (MHR), rate of perceived exertion (RPE) of 11-13 on the Borg scale) continuous training, known as MICT. Pilates breathing exercise enhances lung expansion by focusing on controlled rhythmic breathing methods involving respiratory muscles. Diaphragmatic breathing exercise is slow and controlled deep breathing that has important effects on respiratory system by the modulation of autonomic nervous system. Hypertensive patients will be selected for this study. The study will include three groups. One group will undergo Cycling training with Pilates breathing and the other group will undergo Cycling training with Diaphragmatic breathing and third group will undergo Cycling training only. Before initiating the intervention at the baseline, following outcome measures would be assessed for all the patients: Blood pressure, chest expansion, pulmonary function and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Jan 2026
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2026
CompletedFirst Submitted
Initial submission to the registry
March 27, 2026
CompletedFirst Posted
Study publicly available on registry
April 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 15, 2026
April 14, 2026
March 1, 2026
4 months
March 27, 2026
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Blood Pressure (SBP and DBP)
Evaluation will be performed using a sphygmomanometer to measure Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP). Measurements will be recorded in millimeters of mercury (mmHg) under standardized conditions after at least 5 minutes of seated rest. Two readings will be taken, and the average value will be used for analysis
06 weeks
Chest Expansion
Evaluation will be performed by measuring chest expansion at the xiphoid level using a measuring tape. Chest circumference will be recorded in centimeters (cm) at maximum inspiration and maximum expiration, and chest expansion will be calculated as the difference between these two measurements. Higher values indicate greater chest wall mobility and improved respiratory function, whereas lower values indicate restricted chest expansion.
06 weeks
Pulmonary Function Test
Evaluation will be performed using a spirometer device according to standard guidelines. The parameters assessed will include Forced Expiratory Volume in 1 second (FEV₁), Forced Vital Capacity (FVC), and FEV₁/FVC ratio. Values will be recorded in liters (L) and as percentage of predicted values (%) based on age, sex, height, and ethnicity. Higher values of FEV₁ and FVC indicate better pulmonary function, while a higher FEV₁/FVC ratio indicates reduced airway obstruction and improved respiratory status.
06 weeks
Study Arms (3)
Cycling training with Pilates breathing
EXPERIMENTALParticipants will perform moderate-intensity continuous cycling training with Pilates breathing exercise three times per week for six weeks.
Cycling training with diaphragmatic breathing
EXPERIMENTALParticipants will perform moderate-intensity continuous cycling training combined with diaphragmatic breathing exercise three times per week for six weeks.
Cycling training
ACTIVE COMPARATORParticipants will perform moderate-intensity continuous cycling training only, three times per week for six weeks.
Interventions
Controlled lateral breathing technique focusing on rib cage expansion and core activation performed for 10-15 minutes. A 06 weeks protocol will be followed.
Slow deep breathing emphasizing diaphragmatic movement performed for 10-15 minutes. A 06 weeks protocol will be followed.
Moderate-intensity continuous cycling training performed at 60-79% of maximum heart rate for 20-35 minutes, three sessions per week for six weeks.
Eligibility Criteria
You may qualify if:
- Medically diagnosed patients having Stage 1 hypertension(SBP;140-159 mmHg,DBP:90-99mmHg) and Stage 2 -hypertension(SBP:≥160mmHg,DBP:≥100mmHg) according to JNC 8 Guidelines, referred by a medical specialist or GP or cardiologist from FFH or clinical setups or Hospitals of Rawalpindi/Islambad
- Patients who are on antihypertensive medications for at least 3 months before study.
- Age ranging from 20-55 years
- Both male and female patients.
- Patients who are willing to participate in exercise regime and are able to -provide informed consent, have not been a part of any exercise regime from the last 6 months and well tolerated for exercise after being screened through PAR-Q+
You may not qualify if:
- Patients with Stage 3 hypertension (SBP: ≥180 mmHg or DBP: ≥110 mmHg) and above hypertension according to JNC 8 Guidelines or Hypertensive Crisis etc.
- Patients with any severe knee or other orthopedic conditions that can limit exercise performance
- Patients with uncontrolled hypertension
- History of any abdominal, orthopedic or spinal surgery that could interfere with core or breathing exercise
- Neurological or psychiatric disorders
- Uncontrolled cardiovascular conditions such as arrhythmias or recent myocardial infarction
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foundation University, Islamabad
Islamabad, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will be blinded to the allocation of intervention groups. Rndomization will be performed using sealed envelop method to ensure allocation concealment
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2026
First Posted
April 14, 2026
Study Start
January 12, 2026
Primary Completion (Estimated)
May 15, 2026
Study Completion (Estimated)
May 15, 2026
Last Updated
April 14, 2026
Record last verified: 2026-03